Literature DB >> 1922056

Expression of antisense RNA against initiation factor eIF-4E mRNA in HeLa cells results in lengthened cell division times, diminished translation rates, and reduced levels of both eIF-4E and the p220 component of eIF-4F.

A De Benedetti1, S Joshi-Barve, C Rinker-Schaeffer, R E Rhoads.   

Abstract

HeLa cells were transformed to express antisense RNA against initiation factor eIF-4E mRNA from an inducible promoter. In the absence of inducer, these cells (AS cells) were morphologically similar to control cells but grew four- to sevenfold more slowly. Induction of antisense RNA production was lethal. Both eIF-4E mRNA and protein levels were reduced in proportion to the degree of antisense RNA expression, as were the rates of protein synthesis in vivo and in vitro. Polysomes were disaggregated with a concomitant increase in ribosomal subunits. Translation in vitro was restored by addition of the initiation factor complex eIF-4F but not by eIF-4E alone. Immunological analysis revealed that the p220 component of eIF-4F was decreased in extracts of AS cells and undetectable in AS cells treated with inducer, suggesting that p220 and eIF-4E levels are coordinately regulated. eIF-4A, another component of eIF-4F, was unaltered.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1922056      PMCID: PMC361686          DOI: 10.1128/mcb.11.11.5435-5445.1991

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  62 in total

Review 1.  The role of antisense RNA in gene regulation.

Authors:  P J Green; O Pines; M Inouye
Journal:  Annu Rev Biochem       Date:  1986       Impact factor: 23.643

2.  Two-dimensional gel analyses of the 24-kDa cap binding protein from poliovirus-infected and uninfected HeLa cells.

Authors:  B Buckley; E Ehrenfeld
Journal:  Virology       Date:  1986-07-30       Impact factor: 3.616

3.  Amino acid sequence of the mRNA cap-binding protein from human tissues.

Authors:  W Rychlik; L L Domier; P R Gardner; G M Hellmann; R E Rhoads
Journal:  Proc Natl Acad Sci U S A       Date:  1987-02       Impact factor: 11.205

4.  Structural analysis of the messenger RNA cap-binding protein. Presence of phosphate, sulfhydryl, and disulfide groups.

Authors:  W Rychlik; P R Gardner; T C Vanaman; R E Rhoads
Journal:  J Biol Chem       Date:  1986-01-05       Impact factor: 5.157

5.  Involvement of the 24-kDa cap-binding protein in regulation of protein synthesis in mitosis.

Authors:  A M Bonneau; N Sonenberg
Journal:  J Biol Chem       Date:  1987-08-15       Impact factor: 5.157

6.  Control of cytochrome P1-450 gene expression: analysis of a dioxin-responsive enhancer system.

Authors:  P B Jones; L K Durrin; D R Galeazzi; J P Whitlock
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

7.  A novel BK virus-based episomal vector for expression of foreign genes in mammalian cells.

Authors:  A De Benedetti; R E Rhoads
Journal:  Nucleic Acids Res       Date:  1991-04-25       Impact factor: 16.971

8.  Regulated phosphorylation and low abundance of HeLa cell initiation factor eIF-4F suggest a role in translational control. Heat shock effects on eIF-4F.

Authors:  R Duncan; S C Milburn; J W Hershey
Journal:  J Biol Chem       Date:  1987-01-05       Impact factor: 5.157

9.  Inducible production of c-fos antisense RNA inhibits 3T3 cell proliferation.

Authors:  J T Holt; T V Gopal; A D Moulton; A W Nienhuis
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

10.  mRNA cap-binding protein: cloning of the gene encoding protein synthesis initiation factor eIF-4E from Saccharomyces cerevisiae.

Authors:  M Altmann; C Handschin; H Trachsel
Journal:  Mol Cell Biol       Date:  1987-03       Impact factor: 4.272

View more
  53 in total

1.  Complex formation between potyvirus VPg and translation eukaryotic initiation factor 4E correlates with virus infectivity.

Authors:  S Léonard; D Plante; S Wittmann; N Daigneault; M G Fortin; J F Laliberté
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

2.  High eIF4E, VEGF, and microvessel density in stage I to III breast cancer.

Authors:  Kerry Byrnes; Stephen White; Quyen Chu; Carol Meschonat; Herbert Yu; Lester W Johnson; Arrigo Debenedetti; Fleurette Abreo; Richard H Turnage; John C McDonald; Benjamin D Li
Journal:  Ann Surg       Date:  2006-05       Impact factor: 12.969

3.  Defects in translational regulation mediated by the alpha subunit of eukaryotic initiation factor 2 inhibit antiviral activity and facilitate the malignant transformation of human fibroblasts.

Authors:  Darren J Perkins; Glen N Barber
Journal:  Mol Cell Biol       Date:  2004-03       Impact factor: 4.272

4.  Emerging therapeutics targeting mRNA translation.

Authors:  Abba Malina; John R Mills; Jerry Pelletier
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-04-01       Impact factor: 10.005

Review 5.  Mechanism and regulation of eukaryotic protein synthesis.

Authors:  W C Merrick
Journal:  Microbiol Rev       Date:  1992-06

6.  Translation initiation factors eIF4E and eIFiso4E are required for polysome formation and regulate plant growth in tobacco.

Authors:  Jonathan P Combe; Marie E Petracek; Gerben van Eldik; Frank Meulewaeter; David Twell
Journal:  Plant Mol Biol       Date:  2005-03       Impact factor: 4.076

7.  Regulation of an eukaryotic initiation factor-2 (eIF-2) associated 67 kDa glycoprotein (p67) and its requirement in protein synthesis.

Authors:  S Gupta; S Wu; N Chatterjee; J Ilan; J Ilan; J C Osterman; N K Gupta
Journal:  Gene Expr       Date:  1995

Review 8.  Translational regulation of the heat shock response.

Authors:  J M Sierra; J M Zapata
Journal:  Mol Biol Rep       Date:  1994-05       Impact factor: 2.316

9.  Efficient translation of an SSA1-derived heat-shock mRNA in yeast cells limited for cap-binding protein and eIF-4F.

Authors:  C A Barnes; M M MacKenzie; G C Johnston; R A Singer
Journal:  Mol Gen Genet       Date:  1995-03-10

10.  Understanding and Targeting the Eukaryotic Translation Initiation Factor eIF4E in Head and Neck Cancer.

Authors:  Biljana Culjkovic; Katherine L Borden
Journal:  J Oncol       Date:  2009-12-13       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.